Mitsubishi Tanabe Pharma Corporation
GPTKB entity
Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired |
Mitsubishi Pharma in 2007
Tanabe Seiyaku in 2007 |
| gptkbp:acquisition |
gptkb:Mitsubishi_Pharma_Corporation
|
| gptkbp:ceo |
gptkb:Masayuki_Matsumoto
|
| gptkbp:clinical_trial |
Conducts clinical trials globally
|
| gptkbp:employees |
Approximately 7,000
|
| gptkbp:established |
As a pharmaceutical company in 2007
|
| gptkbp:focus_area |
gptkb:Ophthalmology
gptkb:Oncology gptkb:supply_chain_management gptkb:Biosimilars Cell therapy Gastroenterology Gene therapy Health economics Pain management Regenerative medicine Respiratory diseases Transplantation Urology Pharmaceutical research Quality assurance Infectious diseases Precision medicine Endocrinology Hematology Vaccines Dermatology Regulatory affairs Chronic diseases Nanomedicine Biologics Pharmaceutical manufacturing Pharmacogenomics Pharmaceutical development Patient engagement Health technology assessment Rare diseases Pharmaceutical distribution Pharmaceutical education Real-world evidence Pharmaceutical sales Digital health Pharmaceutical logistics Pharmaceutical marketing Clinical pharmacology Pharmaceutical innovation Artificial intelligence in drug discovery Pharmaceutical partnerships Pharmaceutical collaborations Pharmaceutical consulting Pharmaceutical alliances Pharmaceutical ecosystems Pharmaceutical networks |
| gptkbp:founded |
1678
|
| gptkbp:headcount |
7,000+
|
| gptkbp:headquarters |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma Corporation
|
| gptkbp:market_cap |
¥ 1.5 trillion
|
| gptkbp:parent_company |
gptkb:Mitsubishi_Chemical_Holdings_Corporation
|
| gptkbp:partnerships |
Various global pharmaceutical companies
|
| gptkbp:products |
Pharmaceuticals
|
| gptkbp:research_focus |
gptkb:diabetes
gptkb:Cardiovascular_diseases Immunology Neurology |
| gptkbp:revenue |
¥ 1.1 trillion
|
| gptkbp:stock_exchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stock_symbol |
4508
|
| gptkbp:subsidiaries |
Tanabe Seiyaku Co., Ltd.
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.mt-pharma.co.jp
|
| gptkbp:bfsParent |
gptkb:edaravone
|
| gptkbp:bfsLayer |
5
|